Novavax’s protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data shows

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies.

Novartis’ TV ad for breast cancer drug Kisqali draws untitled letter from FDA

The FDA sent Novartis a reprimand last week claiming “false or misleading” information in a TV commercial for metastatic breast cancer drug Kisqali. The TV

January 23, 2024

CHEPLAPHARM acquires Roaccutane® from Roche – Biotech Investments

EQS-News: Cheplapharm AG / Key word(s): Mergers & Acquisitions CHEPLAPHARM acquires Roaccutane® from Roche 18.01.2024 / 10:13 CET/CEST The issuer is solely responsible for the

January 19, 2024

Fianlimab by Regeneron Pharmaceuticals for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

June 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.